AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AIM ImmunoTech Inc. Director's Dealing 2017

Jun 19, 2017

Director's Dealing

Opens in your device viewer

Issuer: HEMISPHERX BIOPHARMA INC (HEB)
CIK: 0000946644
Period of Report: 2017-06-15

Reporting Person: Rodino Peter W. III (Exec Dir Govt Relations/Secrty)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-15	Options to buy Common Stock	$0.54	A	6671	Acquired	2027-06-15	Common Stock (6671)	Direct

F1: This option is being issued in exchange for a voluntary 20% deduction in salary.